Page 2 - Deciphera Development Pipeline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deciphera development pipeline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deciphera Development Pipeline Today - Breaking & Trending Today

Deciphera Pharmaceuticals, Inc.: Deciphera Announces Approval of QINLOCK in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Seventh Approval Worldwide for QINLOCK and First European Approval - Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines ....

United States , Hong Kong , Jen Robinson , David Rosen , Steve Hoerter , Deciphera Announces Australian Therapeutic Goods Administration Approval , Deciphera Pharmaceuticals , Deciphera Pharmaceuticals Inc , European Union , Committee For Medicinal Products Human Use , Swiss Agency For Therapeutic Products Swissmedic , Deciphera Announces Health Canada Authorization , European Commission , Exchange Commission , Deciphera Press , Zai Lab Press , European Medicines Agency , Clinical Cancer Research , Seventh Approval Worldwide , First European Approval , Swiss Agency , Therapeutic Products , Chief Executive Officer , Medicinal Products , Human Use , Private Securities Litigation Reform Act ,

Ultrarare disease specialists top 2021's pricey drugs list, but Takeda, Merck KGaA meds rank, too

Mar 9, 2021 12:12pm
Eiger BioPharmaceuticals Zokinvy, recently approved by the FDA for ultrarare rapid-aging diseases that affect an estimated 600 children worldwide, is the most expensive drug in U.S. pharmacies in 2021, according to GoodRx.(Jacoblund)
Eiger BioPharmaceuticals in November snagged FDA clearance for Zokinvy for ultra-rare rapid-aging diseases that affect an estimated 600 people worldwide. Orphan drugs that treat small patient populations typically come with high prices, but Zokinvy’s sticker price now beats them all in U.S. pharmacies.
At an estimated monthly price of $86,000, or more than $1 million a year, Zokinvy’s now the most expensive pharmacy drug in the U.S. as of February, according to a list compiled by GoodRx. The ranking focuses on monthly prices and doesn’t include drugs administered by doctors. ....

Eiger Onecare , Zokinvy Orladeyo , Amryt Pharma , Pharma Europe , Merck Kga , Merck Kgaa , Merck Co , Bristol Myers Squibb , Eiger Biopharmaceuticals , Pharma Marketing , Digital Pharma , Biocryst Pharmaceutical , Pharmaceutical Qinlock , Myers Squibb , Viekira Pak , Agios Pharmaceuticals , Biocryst Pharmaceuticals , Idhifa Enasidenib , Rare Diseases , Drug Prices , Orphan Drug , Drug Costs , பார்மா யூரோப் , மெர்க் க்க , மெர்க் இணை , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் ,